Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News GenVec GNVC

Healthcare Biotechnology
"Genvec Inc is a biopharmaceutical company. The Company is engaged in leveraging its proprietary AdenoVerse gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GNVC)

Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition

PR Newswire June 16, 2017

How These Biotech Stocks are Faring? -- Pluristem Therapeutics, BioLine Rx, GenVec, and Diffusion Pharma

PR Newswire April 28, 2017

Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of GenVec, Inc. - GNVC

PR Newswire April 23, 2017

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against GenVec, Inc.

GlobeNewswire April 17, 2017

Research Reports Initiation on Biotech Stocks -- Alnylam Pharma, INSYS Therapeutics, Curis, and GenVec

PR Newswire March 9, 2017

Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results

PR Newswire March 1, 2017

Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and The Western Union Company

PR Newswire February 17, 2017

WeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC Shareholders

PR Newswire February 8, 2017

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of GenVec, Inc. And Encourages Investors To Contact The Firm For Additional Information

Business Wire February 6, 2017
View More News ››

Opinion & Analysis (NDAQ:GNVC)

Swine flu penny stock plays that could resist speculative hype

John Whitefoot May 6, 2009
View More Opinion ››

Bullboard Posts (NDAQ:GNVC)

article: has GNVC tipped its hand?

Interesting take - from the article: "...GNVC fell back to $2.82 today, which translates into a 16% tumble from the recent high. It&...
equityman33 - March 10, 2010

great investor support & sentiment.

the graph's on the ascent amid great investor support & sentiment. If you'd like to know more, the analysis at http://www...
allbull1 - March 3, 2010

Results from Phase 1 Clinical Trial

GenVec, Inc. (GNVC: News, Chart, Quote )announced the results of a Phase I clinical trial of TNFerade inpatients with head and neck...
vforvalue - June 4, 2008

RE: no underlying reason for buying

The psotive results announced today that SurajKGupta is referring to are a good indication of the companies progress in its clinical...
mart33 - May 29, 2008

RE: no underlying reason for buying

I think what is promising about the company is the fact that they have a lot of resources (potential and tangible) to invest because they...
SurajKGupta - May 29, 2008

RE: no underlying reason for buying

I agree. The grants seem to be more of a confidence boost when looking at the total expenses incurred by the company. When looking at its...
gossipgirl - May 28, 2008
View more Bullboard ››

Mandalay Resources Corp.

Mandalay Resources Corp.

Mandalay Resources Corporation is a Canada-based natural resource company with producing assets in Australia (Costerfield ...
View More »